Headquartered in Pasadena, CA, Arrowhead Pharmaceuticals focuses on developing targeted drug therapies using their TRiM platform, which utilizes ligand-mediated delivery to target specific tissues. Their portfolio includes drugs targeting diseases such as hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.